SOPH
ANALYST COVERAGE7 analysts
BUY
+48.5%upside to target
L $7.00
Med $7.50consensus
H $8.00
Buy
686%
Hold
114%
6 Buy (86%)1 Hold (14%)0 Sell (0%)
Full report →
PRICE
Prev Close
4.87
Open
4.90
Day Range4.75 – 5.06
4.75
5.06
52W Range2.59 – 5.70
2.59
5.70
79% of range
VOLUME & SIZE
Avg Volume
102.9K
FUNDAMENTALS
P/E Ratio
-4.3x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.07
Market-like
TECHNICAL
RSI (14)
49
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19

SOPH News

About

sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and swiss precision. sophia genetics offers health professionals who perform clinical genetic testing unparalleled bioinformatics analysis, quality assurance and secure banking of patient dna sequence data generated by ngs. the company helps clinical laboratories to reduce costs, overcome complexity, significantly improve the turnaround time for routine diagnosis and meet quality requirements related to the use of ngs in the clinic. our solution, the sophia ddm™ platform allows hospitals to better and faster diagnose patients using cutting edge ngs analytics algorithms and through knowledge sharing within the largest clinical genomics community in the world (+100 hospitals). the name « sophia » means wisdom in greek and it is the definition of our excellence based

Industry
Data Processing, Hosting, and Related Services
Manuela Da Silva ValenteExecutive Vice President & Chief People Officer
Jurgi CamblongCo-Founder, Chief Executive Officer & Director
Philippe MenuExecutive Vice President, Chief Medical Officer & Chief Product Officer
Zhenyu XuExecutive Vice President & Chief Scientific Officer
Kellen SangerHead of Strategy and Investor Relations
Abhimanyu VermaEVP & Chief Technology Officer
Daan van WellExecutive VP and Chief Legal & Compliance Officer
George A. CardozaExecutive Vice President & Chief Financial Officer
Kevin PuylaertSVP & Chief Sales Officer
Ross Jordan MukenPresident